Previous close | 0.0550 |
Open | 0.0550 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0550 - 0.0550 |
52-week range | 0.0500 - 0.1200 |
Volume | |
Avg. volume | 1,330 |
Market cap | 4.7M |
Beta (5Y monthly) | -2.37 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
TORONTO, September 21, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the second quarter of fiscal 2024, six months ended July 31, 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
TORONTO, August 28, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health" or the "Company") is pleased to announce the appointment of Mr. Bharat Choudhary as the Company’s new permanent Chief Financial Officer (CFO).
TORONTO, July 20, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") is pleased to announce that, further to the Company’s June 15, 2023 press release, it has closed the C$8,000,000 convertible debenture (the "Debenture") financing with Wal-Mart Canada Corp. ("Wal-Mart").